Last reviewed · How we verify

NCT06033053

Real-time Neurofeedback Training of Fronto-limbic Regions Functional Connectivity

Recruiting now NA Last updated 11 April 2024
What this trial tests

NA trial testing Real-time fMRI neurofeedback from Turbo Brain voyager (TBV) 3.2 in Emotion Regulation in 45 participants. Currently enrolling.

Timeline
1 September 2023
Primary endpoint
31 December 2024
31 March 2025

Quick facts

Lead sponsorUniversity of Electronic Science and Technology of China
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment45
Start date1 September 2023
Primary completion31 December 2024
Estimated completion31 March 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

University of Electronic Science and Technology of China

Who can join

Adults 18 to 50, any sex, with Emotion Regulation or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is randomized active-sham group controlled between-subject real-time fMRI neurofeedback trial aimed at modulating the ventromedial prefrontal cortex (vmPFC)-amygdala pathway to control subjective anxiety and arousal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Emotion Regulation

Currently open trials in the same condition.

Other University of Electronic Science and Technology of China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06033053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing